Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Suvorexant in Patients With Effectively Treated Restless Legs Syndrome and Persistent Chronic Insomnia: A Randomized Placebo-Controlled Crossover Trial

NCT04706091 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT04706091
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04706091 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Suvorexant in Patients With Effectively Treated Restless Legs Syndrome and Persistent Chronic Insomnia: A Randomized Placebo-Controlled Crossover Trial
Lead sponsor
Massachusetts General Hospital
Phase
Phase 4
Overall status
Completed
Start date
August 12, 2021
Completion date
October 20, 2023
Enrollment
46 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

insomnia, restless legs syndrome, sleep disorder